PRIYA MANDE

Chief Operating Officer, PsiOxus Therapeutics

Priya Mande is the Chief Operating Officer and Board Director at PsiOxus Therapeutics, a previous Fierce Biotech 15 winner. Today, PsiOxus is known for discovering and developing innovative gene therapy medicines of value for patients with cancer. Over ten years, she has successfully overseen the growth of the company globally, holding responsibility for corporate development, project management, clinical, finance, legal and operations.

Priya has nearly 30 years of experience, 12 of which she spent at GlaxoSmithKline, latterly supporting the R&D Executive. She has helmed roles across research, development, finance and business strategy. This includes responsibility for the vaccine immunotherapeutic portfolio at PowerMed and was the vaccine research project leader for Influenza at Pfizer. She joined PsiOxus in 2010. Priya studied applied biochemistry at Brunel University London and received her MBA with distinction from the London Business School. She was awarded Chartered Director status in 2020 by the UK Institute of Directors.

Since mid 2020 Priya has also been supporting the prestigious UK Government Vaccine Taskforce through the Covid-19 pandemic.

 LIVE ONLINE

16 November 2020

BOOK YOUR PLACE NOW

 LIVE ONLINE

17 November 2020

BOOK YOUR PLACE NOW